INmune Stock Future Price Prediction


USD 6.91  0.05  0.72%   

INmune Bio stock price prediction is an act of determining the future value of INmune Bio shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of INmune Bio's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of INmune Bio and does not consider all of the tangible or intangible factors available from INmune Bio's fundamental data. We analyze noise-free headlines and recent hype associated with INmune Bio, which may create opportunities for some arbitrage if properly timed.
Please see INmune Bio Basic Forecasting Models to cross-verify your projections.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of INmune Bio based on different types of headlines from major news networks to social media. The INmune stock price prediction module provides an analysis of price elasticity to changes in media outlook on INmune Bio over a specific investment horizon.
EPS Estimate Next Quarter
EPS Estimate Current Year
EPS Estimate Next Year
Wall Street Target Price
EPS Estimate Current Quarter
Quarterly Revenue Growth YOY
Using INmune Bio hype-based prediction, you can estimate the value of INmune Bio from the perspective of INmune Bio response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards INmune Bio using INmune Bio's stock options and short interest. It helps to benchmark the overall future attitude of investors towards INmune using crowd psychology based on the activity and movement of INmune Bio's stock price.
INmune Bio Total Assets Per Share are projected to slightly grow based on the last few years of reporting. The past year's Total Assets Per Share were at 5.60. The current year Net Current Assets as percentage of Total Assets is expected to grow to 84.47, whereas Cash Flow Per Share is forecasted to decline to (1.64) .

INmune Bio Short Interest

A significant increase or decrease in INmune Bio's short interest from the previous month could be a good indicator of investor sentiment towards INmune. Short interest can provide insight into the potential direction of INmune Bio stock and how bullish or bearish investors feel about the market overall. An investor who is long INmune Bio may also wish to track short interest. As short interest increases, investors should be becoming more worried about INmune Bio and may potentially protect profits, hedge INmune Bio with its derivative instruments, or be ready for some potential downside.
200 Day MA
Short Percent
Short Ratio
Shares Short Prior Month
939.3 K
50 Day MA
Shares Short
910.3 K

INmune Bio Hype to Price Pattern

Investor biases related to INmune Bio's public news can be used to forecast risks associated with investment in INmune. The trend in average sentiment can be used to explain how an investor holding INmune can time the market purely based on public headlines and social activities around INmune Bio. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of INmune Bio's market sentiment to its price can help taders to make decisions based on the overall investors consensus about INmune Bio.

INmune Bio Implied Volatility

INmune Bio's implied volatility exposes the market's sentiment of INmune Bio stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if INmune Bio's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that INmune Bio stock will not fluctuate a lot when INmune Bio's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in INmune Bio. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in INmune Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying INmune because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

INmune Bio after-hype prediction price

  USD 6.89  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of INmune Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of INmune Bio in the context of predictive analytics.
LowReal ValueHigh
2 Analysts
LowTarget PriceHigh
Estimates (1)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as INmune Bio. Your research has to be compared to or analyzed against INmune Bio's peers to derive any actionable benefits. When done correctly, INmune Bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in INmune Bio.

INmune Bio After-Hype Price Prediction Density Analysis

As far as predicting the price of INmune Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in INmune Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of INmune Bio, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

INmune Bio Estimiated After-Hype Price Volatility

In the context of predicting INmune Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on INmune Bio's historical news coverage. INmune Bio's after-hype downside and upside margins for the prediction period are 2.80 and 10.98, respectively. We have considered INmune Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 6.91
After-hype Price
INmune Bio is somewhat reliable asset. Analysis and calculation of next after-hype price of INmune Bio is based on 3 months time horizon.

INmune Bio Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as INmune Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading INmune Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with INmune Bio, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.08  4.12   0.02   0.07  4 Events / Month1 Events / MonthIn about 4 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

INmune Bio Hype Timeline

INmune Bio is currently traded for 6.91. The entity has historical hype elasticity of -0.02 and average elasticity to hype of competition of 0.07. INmune is expected to decline in value after the next headline with the price expected to drop to 6.89. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next newsis expected to be -0.29% whereas the daily expected return is currently at -0.08%. The volatility of related hype on INmune Bio is about 492.43% with expected price after next announcement by competition of 6.98. About 35.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.89. Some equities with similar Price to Book (P/B) outperform the market in the long run. INmune Bio recorded a loss per share of 1.92. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 4 days.
Please see INmune Bio Basic Forecasting Models to cross-verify your projections.

INmune Bio Related Hype Analysis

Having access to credible news sources related to INmune Bio's direct competition is more important than ever and may enhance your ability to predict INmune Bio's future price movements. Getting to know how INmune Bio rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how INmune Bio may potentially react to the hype associated with one of its peers.

INmune Bio Additional Predictive Modules

Most predictive techniques to examine INmune price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for INmune using various technical indicators. When you analyze INmune charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About INmune Bio Predictive Indicators

The successful prediction of INmune Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as INmune Bio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of INmune Bio based on analysis of INmune Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to INmune Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to INmune Bio's related companies.
 2010 2021 2022 (projected)
Accounts Payable Turnover0.0097030.06750.0728
Receivables Turnover0.0096580.05490.0592

Story Coverage note for INmune Bio

The number of cover stories for INmune Bio depends on current market conditions and INmune Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that INmune Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about INmune Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

INmune Bio Short Properties

INmune Bio's future price predictability will typically decrease when INmune Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of INmune Bio often depends not only on the future outlook of the potential INmune Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. INmune Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding17329379.00
Cash And Short Term Investments74810000.00
Please see INmune Bio Basic Forecasting Models to cross-verify your projections. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for analysis

When running INmune Bio price analysis, check to measure INmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INmune Bio is operating at the current time. Most of INmune Bio's value examination focuses on studying past and present price action to predict the probability of INmune Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move INmune Bio's price. Additionally, you may evaluate how the addition of INmune Bio to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Bond Directory
Find actively traded corporate debentures issued by US companies
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
CEO Directory
Screen CEOs from public companies around the world
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is INmune Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of INmune Bio. If investors know INmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about INmune Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
124.1 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of INmune Bio is measured differently than its book value, which is the value of INmune that is recorded on the company's balance sheet. Investors also form their own opinion of INmune Bio's value that differs from its market value or its book value, called intrinsic value, which is INmune Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because INmune Bio's market value can be influenced by many factors that don't directly affect INmune Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between INmune Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine INmune Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, INmune Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.